Evidence map›Paper›PMID 39921150›Full record

ArticleBrain, behavior, and immunity2025

Regional brain structural alterations in reward and salience networks in asthma.

Danielle Carrol, William W Busse, Corrina J Frye, Danika R Klaus, Julia C Bach, Heather Floerke, Barbara B Bendlin, Henrik Zetterberg, Kaj Blennow, Amanda Heslegrave and 2 more

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Danielle CarrolCenter for Healthy Minds, University of Wisconsin-Madison Madison WI USA.
William W BusseDepartment of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health Madison WI USA.
Corrina J FryeWasiman Center, University of Wisconsin-Madison Madison WI USA.
Danika R KlausDepartment of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health Madison WI USA.
Julia C BachDepartment of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health Madison WI USA.
Heather FloerkeDepartment of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health Madison WI USA.
Barbara B BendlinWisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison Madison WI USA.
Henrik ZetterbergWisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison Madison WI USA; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital Mölndal Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square London UK; UK Dementia Research Institute at UCL London UK; Hong Kong Center for Neurodegenerative Diseases Clear Water Bay Hong Kong, China.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital Mölndal Sweden; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University Paris France; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC Hefei China.
Amanda HeslegraveClinical Neurochemistry Laboratory, Sahlgrenska University Hospital Mölndal Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square London UK.
Rachel HoelCenter for Healthy Minds, University of Wisconsin-Madison Madison WI USA.
Melissa A RosenkranzCenter for Healthy Minds, University of Wisconsin-Madison Madison WI USA; Department of Psychiatry, University of Wisconsin-Madison, USA. Electronic address: marosenk@wisc.edu.

Funding

Wisconsin Center for the Neuroscience and Psychophysiology of MeditationP01AT004952 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI DAVIDSON, RICHARD J · 2008 to 2018
$14.7M
TRAINING PROGRAM IN EMOTION RESEARCHT32MH018931 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI Richard J Davidson · 1989 to 2026
$11.6M
Waisman Intellectual and Developmental Disabilities Research Center Down Syndrome RegistryU54HD090256 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 2016 to 2020
$6.0M
Asthmatic Inflammation and Neurocircuitry ActivationR01HL123284 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BUSSE, WILLIAM W. · 2016 to 2019
$2.9M
Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factorRF1AG082215 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI JARJOUR, NIZAR N, ROSENKRANZ, MELISSA A · 2023 to 2023
$2.3M
Whole-Person Health and Brain Health Outcomes of Mindfulness Training in AsthmaF31AT012583 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI CARROL, DANIELLE H · 2024 to 2025
$69k
NCCIH NIH HHS F31 AT012583NCCIH NIH HHS P01 AT004952NHLBI NIH HHS R01 HL123284NIA NIH HHS RF1 AG082215NICHD NIH HHS U54 HD090256NIMH NIH HHS T32 MH018931
6 · The paper itself

Abstract

introductionChronic systemic inflammation is highly prevalent and has deleterious effects on the brain, impacting both function and structure, and manifesting in elevations in psychological symptoms transdiagnostically. Asthma is a chronic inflammatory disease of the airway that affects more than 300 million people worldwide and is known to be highly comorbid with psychological and cognitive dysfunction. Though a growing corpus of work has identified functional brain abnormalities associated with asthma, limited research has investigated structural differences which may partially underlie functional changes. Identifying and characterizing asthma-related structural brain changes will shed light on the neurobiology through which asthma impacts mental function and has the potential to inform prophylaxis and treatment.

methodsWe examined differences in regional brain volume, cortical thickness, and surface area, in 128 individuals with asthma compared to 134 non-asthma healthy controls. Five regions of interest were examined a priori, based on their previous implication in inflammation-related functional consequences (dorsal and ventral striatum, pallidum, and insula), or previous evidence of asthma-related structural impact (hippocampus and thalamus). We supplemented our region of interest approach with a voxel-wise whole-brain analysis. Additionally, we examined the association of brain structure with depression symptoms, asthma severity, degree of inflammation, and plasma biomarkers of neuroinflammation, neurodegeneration, and Alzheimer's disease specific pathology.

resultsCompared to non-asthma control participants, those with asthma had smaller nucleus accumbens volumes, thicker orbitofrontal cortices, larger middle frontal cortex surface areas, and greater diencephalon volumes. Those with more severe asthma had smaller nucleus accumbens and dorsal striatal volumes, reduced anterior cingulate cortex surface area, and greater amygdala volume compared to those with mild asthma. In untreated asthma patients, greater depressive symptoms were associated with smaller striatal volume, suggesting a potential CNS-protective effect of medications that reduce airway inflammation in asthma. In addition, a plasma marker of astrogliosis was associated with larger diencephalon, cerebellum, brainstem, and thalamus volumes, but reduced insula thickness and surface area.

conclusionsPatterns of structural brain changes in participants with asthma encompass key regions of reward and salience networks, which may in part give rise to the functional alterations in these networks characteristic of chronic systemic inflammation.

Indexed as

AsthmaBrainAdultDepressionFemaleHumansInflammationMagnetic Resonance ImagingMaleMiddle AgedRewardAsthmaDepressionGFAPInflammationMRIReward networkSalience network

Identifiers

PMID39921150
PMCPMC12003077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.